Rx (Prescription Medicine)
USD $ 120.00
Eleftha 440mg 注射剂是一种含有活性成分 Pemetrexed 的强效药物。它是一种化疗药，通过抑制某些对癌细胞生长与复制必不可少的酶而发挥作用。通过干扰这些过程，Eleftha 有助于减缓或停止特定癌症的进展。主要适用于非小细胞肺癌（NSCLC）和恶性胸膜间皮瘤的治疗。Eleftha 440mg 注射剂的剂量与用法由合格的医疗专业人员根据患者的病情、对治疗的反应以及其他个体因素决定。常见不良反应可能包括疲劳、恶心、呕吐、食欲不振、脱发以及骨髓抑制（血细胞计数下降）。患者还可能出现口腔溃疡、腹泻和皮疹。若出现任何不寻常或严重的不良反应，请立即向医生报告。Eleftha 440mg 注射剂应储存在室温、避光并放在儿童接触不到的地方。该药物通过静脉注射由医疗专业人员给予。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength |
其他品牌的 Trastuzumab 440 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
